RVXCF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Jan 13 closing price
Capitalization
19.66M
Intraday BUY SELL Signals
TELIF
Price
$0.32
Change
-$0.03 (-8.57%)
Updated
Jan 15 closing price
Capitalization
17.42M
Intraday BUY SELL Signals
Interact to see
Advertisement

RVXCF vs TELIF

Header iconRVXCF vs TELIF Comparison
Open Charts RVXCF vs TELIFBanner chart's image
Resverlogix
Price$0.07
Change-$0.00 (-0.00%)
Volume$54.08K
Capitalization19.66M
TELESCOPE INNOVATIONS
Price$0.32
Change-$0.03 (-8.57%)
Volume$195.69K
Capitalization17.42M
RVXCF vs TELIF Comparison Chart in %
RVXCF
Daily Signal:
Gain/Loss:
TELIF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RVXCF vs. TELIF commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVXCF is a Hold and TELIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (RVXCF: $0.07 vs. TELIF: $0.32)
Brand notoriety: RVXCF and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVXCF: 161% vs. TELIF: 139%
Market capitalization -- RVXCF: $19.66M vs. TELIF: $17.42M
RVXCF [@Biotechnology] is valued at $19.66M. TELIF’s [@Biotechnology] market capitalization is $17.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVXCF’s FA Score shows that 0 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • RVXCF’s FA Score: 0 green, 5 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, TELIF is a better buy in the long-term than RVXCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVXCF’s TA Score shows that 5 TA indicator(s) are bullish while TELIF’s TA Score has 7 bullish TA indicator(s).

  • RVXCF’s TA Score: 5 bullish, 5 bearish.
  • TELIF’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TELIF is a better buy in the short-term than RVXCF.

Price Growth

RVXCF (@Biotechnology) experienced а -5.34% price change this week, while TELIF (@Biotechnology) price change was +0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.20%. For the same industry, the average monthly price growth was +4.47%, and the average quarterly price growth was +43.25%.

Industries' Descriptions

@Biotechnology (+0.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVXCF($19.7M) has a higher market cap than TELIF($17.4M). TELIF YTD gains are higher at: 25.078 vs. RVXCF (-4.825). TELIF has higher annual earnings (EBITDA): -1.32M vs. RVXCF (-2.76M). TELIF has more cash in the bank: 1.11M vs. RVXCF (64K). TELIF has less debt than RVXCF: TELIF (2.22M) vs RVXCF (19.5M). TELIF has higher revenues than RVXCF: TELIF (3.97M) vs RVXCF (0).
RVXCFTELIFRVXCF / TELIF
Capitalization19.7M17.4M113%
EBITDA-2.76M-1.32M210%
Gain YTD-4.82525.078-19%
P/E RatioN/A85.38-
Revenue03.97M-
Total Cash64K1.11M6%
Total Debt19.5M2.22M879%
FUNDAMENTALS RATINGS
RVXCF: Fundamental Ratings
RVXCF
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVXCFTELIF
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 19 days ago
63%
Bullish Trend 26 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 10 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RVXCF
Daily Signal:
Gain/Loss:
TELIF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARW118.652.65
+2.28%
Arrow Electronics
BX160.812.10
+1.32%
Blackstone
LEGT10.89N/A
N/A
Legato Merger Corp
PLTK3.56-0.07
-1.93%
Playtika Holding Corp
ANTX1.25-0.06
-4.58%
AN2 Therapeutics

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and TELIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and TELIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
N/A
TELIF - RVXCF
22%
Poorly correlated
-9.72%
GRCE - RVXCF
21%
Poorly correlated
N/A
FULC - RVXCF
20%
Poorly correlated
+0.19%
NEUP - RVXCF
20%
Poorly correlated
+1.49%
SQZB - RVXCF
20%
Poorly correlated
N/A
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
-9.72%
ATNM - TELIF
31%
Poorly correlated
-1.50%
RVXCF - TELIF
22%
Poorly correlated
N/A
ENTX - TELIF
20%
Poorly correlated
-3.07%
ACUT - TELIF
11%
Poorly correlated
N/A
REVB - TELIF
9%
Poorly correlated
-0.01%
More